Is Bydureon still available to buy?
Bydureon (extended-release exenatide) is no longer widely available in the way it used to be, and availability can vary by country and by the specific formulation (the weekly injection vs. other exenatide products). In the U.S., many patients and pharmacies have seen it replaced over time by other exenatide options and alternative weekly GLP-1 therapies as the market and product offerings changed.
What changed with Bydureon’s product/formulation?
Bydureon has been sold in different branded forms historically, and over time newer or re-packaged products and competing GLP-1 medicines have reduced routine use of the original branded product. If you’re trying to fill a prescription, the key practical question is which exact product your prescriber ordered and what your pharmacy can source locally.
What should you check with your pharmacy?
When asking whether it’s on the market for your location, ask your pharmacist for:
- The exact NDC/product you need (sometimes “Bydureon” gets used as a general label, but the exact item matters for supply).
- Whether they can order it through standard wholesalers.
- Whether a therapeutically equivalent alternative is available (same weekly exenatide or a different weekly GLP-1).
What alternatives might replace it if it’s out of stock or discontinued?
If Bydureon can’t be sourced, prescribers commonly switch patients to another GLP-1 option (often other weekly injectable medicines) or to a different exenatide formulation depending on coverage and clinical fit. The right substitute depends on your diabetes regimen, insurance, and tolerance.
Can you confirm for your country or pharmacy?
If you tell me your country (and whether you mean the weekly injection) and what dose your prescription is for, I can narrow the answer to what’s typically available and what alternatives are most likely.
Sources (for product-market tracking):
- DrugPatentWatch – Byetta/Bydureon-related tracking